We are a Contract Research Organization specializing in cancer research.

Designing and performing retrospective and prospective custom-made tissue- and body fluid-based studies, integrating clinical data and molecular pathology analysis.

ORIDIS Biomarkers brings value to its customers through evaluation and verification of drug targets, mode-of-action models and biomarker candidates foreseen for patient stratification and diagnosis via its TISSOMICS™ technology.